The 212,000-sf building located at 131 Morristown Rd. in Basking Ridge, NJ, Somerset County, is owned by Unilever U.S., and it used to be occupied by AT&T, which vacated the premises this past spring. But the sizable chunk of class A space wasn’t on the market for very long: United Healthcare has signed a lease for the entire building, where it plans to house the U.S. headquarters of its Ingenix Pharmaceuticals division.

The pharmaceutical industry has arguably been the most active segment in New Jersey real estate this year, including some of the largest deals of the year, so it’s no surprise that the space, one of the largest blocks recently available, was quickly snapped up by a company in that field.

Peter Blanchard, a principal in The Garibaldi Group of Chatham, NJ, and Charles E. Snyder, vice president of the Trammell Crow Co., represented United Healthcare in the transaction with owner Unilever U.S.

The deal will bring yet another pharmaceutical name—in the form of a service company—to the New Jersey landscape. So far this year, pharma and related companies involved in transaction activity in the Garden State have included Novartis, Schering-Plough, Johnson & Johnson, Atlantic Health Systems, American Home Products and LifeCell to name a few.

Ingenix, which will bring a total of more than 1,000 jobs to the site, is said to be one of the fastest growing information technology companies involved in the healthcare industry. The company serves multiple market segments on a business-to-business basis, including health insurers and other payers, care providers, large employers and governments. Said to be the largest health information and research provider in the country, the company’s officials project that their revenues will top the $400 million mark this year.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dig Deeper



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join now!

  • Free unlimited access to's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including and

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2023 ALM Global, LLC. All Rights Reserved.